Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Géraldine Pignot

7PUBLICATIONS
71CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisMedical biotechnology diagnostics (incl. biosensors)Pacific Peoples life course
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

Sort by Publication Date:
|Jan 03, 2025
The effect of tumor downsizing on surgical complexity during nephrectomy after immune checkpoint inhibitors for metastatic renal cell carcinoma.

Geraldine Pignot, Gaelle Margue, Pierre Bigot

|Dec 17, 2024
Sex Disparities in Bladder Cancer Diagnosis and Treatment.

Géraldine Pignot, Philippe Barthélémy, Delphine Borchiellini

|Mar 11, 2023
Is CIS a Contraindication to Hyperthermic Intravesical Chemotherapy (HIVEC) after BCG-Failure?

Vassili Anastay, Michael Baboudjian, Alexandra Masson-Lecomte

|Feb 22, 2023
Efficacy of hyperthermic intravesical chemotherapy (HIVEC) in patients with non-muscle invasive bladder cancer after BCG failure.

Géraldine Pignot, Michael Baboudjian, Cédric Lebacle

|Aug 05, 2022
Escherichia coli-Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer.

Anne-Gaëlle Goubet, Leonardo Lordello, Carolina Alves Costa Silva

|Mar 06, 2022
External validation of the computerized analysis of TRUS of the prostate with the ANNA/C-TRUS system: a potential role of artificial intelligence for improving prostate cancer detection.

Vito Lorusso, Boukary Kabre, Geraldine Pignot

Pageof 2

Frequent Collaborators

2 joint publications

Gwenaelle Gravis

2 joint publications

Cédric Lebacle

1 joint publications

Rajae Touzani

1 joint publications

Vito Lorusso

1 joint publications

Boukary Kabre

1 joint publications

Serge Brunelle

1 joint publications

Nicola Nicolai

1 joint publications

Gennaro Musi

1 joint publications

Emanuele Montanari

1 joint publications

Ottavio de Cobelli

Frequent Collaborators

2 joint publications

Gwenaelle Gravis

2 joint publications

Cédric Lebacle

1 joint publications

Rajae Touzani

1 joint publications

Vito Lorusso

Top Related Videos

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on : Apr 12, 2017

13.5K
An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment
08:43

An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment

Published on : Jul 28, 2012

14.7K
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice:  A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

21.3K
See more related videos

Top Related Videos

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on : Apr 12, 2017

13.5K
An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment
08:43

An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment

Published on : Jul 28, 2012

14.7K
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice:  A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

21.3K
See more related videos